🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10452+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 10452 recruiting trials

Phase 2RecruitingNCT06904196

Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC

👨‍⚕️ Mingyue Cai, Dr., Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06904183

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

👨‍⚕️ Kangshun Zhu, Dr., Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Apr 2025View details ↗
Phase 3Enrolling by InvitationNCT06859099

Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

🏥 Sanofi📍 43 sites📅 Started Apr 2025View details ↗
NARecruitingNCT06978504

Impact of Genetic Polymorphisms And DASH Diet On Weight Loss Progression In Climacteric Women With Metabolic Syndrome

🏥 Nutrindo Ideais Research Center📍 1 site📅 Started Apr 2025View details ↗
Enrolling by InvitationNCT06969586

The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy

👨‍⚕️ Josip Pavan, prof.dr.sc., University Hospital Dubrava📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06949670

Alpha-Synuclein PET/CT in Various α-Syn-Related Disease

🏥 Tianjin Medical University📍 2 sites📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT07448324

Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL

🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT07012447

Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

👨‍⚕️ Yue-jun Liu, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06914648

The Dragon PLC Trial (DRAGON-PLC)

🏥 Maastricht University📍 55 sites📅 Started Apr 2025View details ↗
RecruitingNCT06724562

IL1 Inhibition in FOP

👨‍⚕️ Edward Hsiao, MD, PhD, University of California, San Francisco📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06894550

Short-term Exposure to High Altitude in Patients With Asymptomatic Aortic Stenosis

👨‍⚕️ Thomas Pilgrim, MD, MSc, University Hospital of Bern, Bern, Switzerland📍 1 site📅 Started Apr 2025View details ↗
Enrolling by InvitationNCT07028814

Risk Informed Obesity Care Plan Pilot

🏥 Massachusetts General Hospital📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06803693

Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

🏥 Ruijin Hospital📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT07136636

Speech of Kids After Neonatal Encephalopathy

🏥 Semmelweis University📍 1 site📅 Started Apr 2025View details ↗
EARLY_Phase 1RecruitingNCT06972602

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

🏥 Eye & ENT Hospital of Fudan University📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06838039

Assessing the Impact of Additional Serratus Anterior Block Within 24-Hour on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients

🏥 Al-Quds University📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06643286

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

🏥 Erasmus Medical Center📍 4 sites📅 Started Apr 2025View details ↗
RecruitingNCT07118631

Clinical Study on Emergency Treatment of Cerebral Arteriovenous Malformation Bleeding

🏥 Beijing Tiantan Hospital📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06922994

Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

👨‍⚕️ Claudio Tondo, Centro Cardiologico Monzino IRCCS📍 5 sites📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06898450

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

👨‍⚕️ Anita Scheuber, MD, PhD, Nimbus Therapeutics, Inc.📍 29 sites📅 Started Mar 2025View details ↗
← PreviousPage 129 of 523Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →